Kardigan, Inc. is a clinical-stage precision therapeutics company, which engages in developing medicines that target the root cause of specific cardiovascular diseases where no approved treatments exist. It combines clinical-stage drug programs with artificial intelligence, real-world patient data, and analytics through its “Cardiac Intelligence” platform to accelerate research and improve treatment outcomes. The company was founded by Tassos E. Gianakakos, Jay Edelberg, Bob McDowell, Leslie Leinwand, and Elizabeth McNally in August 2023 and is headquartered in Princeton, NJ.
Sector:
Health Technology
Industry:
Biotechnology
Employees:
210
Frequently Asked Questions
What is Market Cap of Kardigan Inc.?
Market cap, also known as market capitalization, is the total market value of a company. It's calculated by multiplying the current market price by the total number of shares outstanding. Kardigan Inc. market cap is $4.35B.
What is the 52-week high for Kardigan Inc.?
52 week high is the highest price of a stock in the past 52 weeks, or one year. Kardigan Inc. 52 week high is $27.00 as of July 09, 2026.
What is the 52-week low for Kardigan Inc.?
52 week low is the lowest price of a stock in the past 52 weeks, or one year. Kardigan Inc. 52 week low is $16.00 as of July 09, 2026.
What is Kardigan Inc. stock price today?
Kardigan Inc. stock price today is $22.22.
What was Kardigan Inc. stock price yesterday?
Kardigan Inc. stock price yesterday was $23.83.
What is the Price-to-Book ratio of Kardigan Inc.?
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It's calculated by dividing a company's market capitalization by its book value. Kardigan Inc. P/B ratio is -6.6033.
What is the 50-day moving average of Kardigan Inc.?
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It's calculated by averaging the closing stock price over the previous 50 trading days. Kardigan Inc. 50-day moving average is $22.80.